Ferrous Citrate

CHEMBL2110914 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
246.0 g/mol
LogP
Phase
4

An iron supplement used to treat or prevent iron deficiency anemia, particularly in patients with chronic kidney disease or those at risk for malaria-related anemia. It provides bioavailable ferrous iron to support red blood cell production and restore healthy iron levels in the body.

Berat Molekul

245,9500 g/mol

TPSA

138,00 Ų

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.[Fe+2]

InChI

InChI=1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+2/p-2

Molecular Formula

C6H6FeO7

HBD / HBA

2 / 7

Ikatan yang Dapat Dirotasi

3

Atom Berat

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An iron supplement used to treat or prevent iron deficiency anemia, particularly in patients with chronic kidney disease or those at risk for malaria-related anemia. It provides bioavailable ferrous iron to support red blood cell production and restore healthy iron levels in the body.

Yes, Ferrous Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110914. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11064683. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.